GSK

GlaxoSmithKline (GSK) has reportedly revealed plans to cut ‘several hundred’ sales and research jobs in the US.

The cuts are part of its global restructuring strategy and cost-saving programme.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

In a letter filed with North Carolina Department of Commerce, GSK confirmed 900 positions will be affected from the company’s Research Triangle Park (RTP) site in North Carolina, Philadelphia and in field offices across the US.

In an emailed statement, a GSK spokesperson was quoted by Reuters saying: "This is a significant programme and will result in the loss of several hundred employees in the US commercial business and a similar number in R&D activities based in the US."

GSK employs 4,500 staff and contractors in RTP, including 2,500 who work in R&D.

See Also:

"The cuts will not affect retail sales teams focused on launching new medicines, including the employees at GSK’s manufacturing facility in Zebulon, US."

Reports also emerged that the company’s 17,000 staff in commercial and research operations in the US were made aware about redundancy plans and changes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company was cited by CharlotteObserver.com saying it will eliminate 450 positions in the second quarter of next year, while the remaining cuts will be implemented by the end of 2015.

A spokesman said: "Cuts are not being made across the board but are strategic, focused changes to allow GSK to operate more efficiently.

"This is a rescaling of work to reflect market forces that were anticipated but that have accelerated and are affecting the entire industry."

The cuts will not affect retail sales teams focused on launching new medicines, including the employees at GSK’s manufacturing facility in Zebulon, US.

Image: GlaxoSmithKline headquarters in Brentford, London, England. Photo: courtesy of Maxwell Hamilton.